| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 531.210 | 650.525 | 612.060 | 610.778 | 710.750 | 771.896 | 700.076 | 388.396 | 294.809 | 214.644 |
| Total Income - EUR | 531.373 | 650.643 | 612.097 | 610.778 | 710.750 | 789.703 | 700.076 | 668.341 | 294.816 | 214.648 |
| Total Expenses - EUR | 511.620 | 620.440 | 573.620 | 579.619 | 662.651 | 758.774 | 672.677 | 478.492 | 280.524 | 208.119 |
| Gross Profit/Loss - EUR | 19.753 | 30.202 | 38.477 | 31.159 | 48.099 | 30.928 | 27.399 | 189.849 | 14.292 | 6.530 |
| Net Profit/Loss - EUR | 16.429 | 22.520 | 27.495 | 25.051 | 40.991 | 23.031 | 20.886 | 183.557 | 11.344 | 5.434 |
| Employees | 7 | 6 | 7 | 7 | 8 | 8 | 7 | 1 | 1 | 1 |
Check the financial reports for the company - Sirelexin Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 129.318 | 124.970 | 120.504 | 117.019 | 114.060 | 111.219 | 108.088 | 14.312 | 13.843 | 13.428 |
| Current Assets | 299.295 | 301.265 | 272.840 | 311.305 | 298.332 | 271.782 | 263.196 | 262.929 | 98.703 | 85.152 |
| Inventories | 270.127 | 234.800 | 205.153 | 207.031 | 207.626 | 209.119 | 201.322 | 79.711 | 62.152 | 65.064 |
| Receivables | 25.606 | 41.596 | 25.719 | 47.373 | 11.206 | 35.533 | 36.208 | 151.872 | 21.189 | 8.161 |
| Cash | 3.562 | 24.869 | 41.968 | 56.902 | 79.500 | 27.130 | 25.666 | 31.346 | 15.361 | 11.927 |
| Shareholders Funds | 228.339 | 202.336 | 204.515 | 198.640 | 218.400 | 178.860 | 137.560 | 209.883 | 61.892 | 57.381 |
| Social Capital | 103.487 | 102.432 | 100.698 | 98.850 | 96.936 | 95.098 | 92.989 | 2.028 | 2.022 | 2.010 |
| Debts | 205.366 | 228.938 | 193.783 | 234.547 | 198.762 | 204.140 | 233.725 | 67.358 | 50.654 | 41.199 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4673 - 4673" | |||||||||
| CAEN Financial Year |
4752
|
|||||||||
Comments - Sirelexin Srl